Urine Metabolites in the Diagnosis of Disease | MicrobiomeTrials← Back to trialsNCT06710067
Urine Metabolites in the Diagnosis of Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-10-01Est. Completion: 2025-09
Enrollment target: 1,250 participants Locations- Unio Health Partners (Gastroenterology), Encinitas, California, United States
- Digestive Health Associates, Santa Monica, California, United States
- Westside Gastro Care, Santa Monica, California, United States
- Bass Medical Group (Gastroenterology), Walnut Creek, California, United States
Other microbiome trials you might be interested in
Prostate CancerLeukemiaBreast CancerMelanomaColorectal Cancer
Study Description:
ELEA is an observational cohort study that will collect exposure information and biospecimens from t…
Bethesda, United StatesCompleted Dec 23, 2027
Colorectal Adenocarcinoma
Colorectal cancer is one of the most common cancers worldwide. Although surgery and drug treatments have improved, some …
Nice, FranceEst. completion Oct 1, 2027
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell CarcinomaStage IIB Anal Cancer AJCC v8Stage III Anal Cancer AJCC v8
This phase III trial investigates how well nivolumab after combined modality therapy works in treating patients with hig…
Birmingham, United StatesEst. completion Dec 31, 2027